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Abstract: This paper describes the structure and function of the normal synovium including the cellular content, nerve 
and vascular supply and how normal synovium maintains homeostasis within the joint. It is important to understand 
normal synovium before appreciating the changes that occur in the synovial membrane which leads to the pathology seen 
in inflammatory arthritides such as Rheumatoid Arthritis. 
Keywords: Normal synovial membrane, structure, function, nerve supply, vascular supply, alterations in inflammatory 
arthritis. 
INTRODUCTION 
  The term synovium refers to the soft tissue lining the 
spaces of diarthrodial joints, tendon sheaths and bursae. It 
includes the continuous surface layer of cells (intima) and 
the underlying tissue (subintima). The intima consists of 
macrophages and ﬁbroblasts while the subintima includes 
blood and lymphatic vessels, a cellular content of both 
resident  ﬁbroblasts and inﬁltrating cells in a collagenous 
extracellular matrix [1]. Between the intimal surfaces is a 
small amount of fluid, usually rich in hyaluronan (hyaluronic 
acid). Together, this structure provides a non-adherent 
surface between tissue elements. Unlike serosal surfaces 
which also have non-adherent properties, synovium is 
derived from ectoderm and does not contain a basal lamina. 
  The synovium is the central area of pathology in a 
number of inflammatory joint diseases, including rheumatoid 
arthritis (RA) and spondyloarthritis (SpA). However our 
knowledge of the immuno-histochemical architecture of the 
synovial membrane, particularly in normal subjects, is 
surprisingly limited. The normal synovial membrane is 
stated to be a relatively acellular structure consisting of a 
distinct intimal lining layer of 1-2 cells thickness and a 
synovial sublining layer. The latter is relatively acellular, 
containing scattered blood vessels, fat cells, and fibroblasts, 
with few lymphocytes or macrophages. Typically, the 
normal synovium contains an intimal layer which is 20-
40mm thick in cross-section and an areolar subintima which 
can be up to 5mm in thickness. At many sites there is no 
discrete membrane, especially where subintima consists of 
fat pad or ﬁbrous tissue. However, often there is 
considerable variation of the typical normal synovium 
appearance, including absence of intimal cells [1-3]. 
Superﬁcial bursae may contain little or no hyaluronan-rich 
fluid. Ganglia are sacs containing hyaluronan-rich fluid but 
do not occur at sites of shearing and do not have a typical 
intima and so may not really be synovial tissue at all. 
Diseased synovial tissue may lose any recognizable lining   
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structure and only be deﬁnable by its relation to a joint. In 
patients with inflammatory arthritis, such as RA, the intimal 
lining layer is usually markedly thickened, mainly due to an 
increase in CD68 positive macrophages, with a heavily 
infiltrated subintimal region, containing T and B 
lymphocytes, plasma cells, and macrophages, associated 
with stromal oedema and proliferation of blood vessels. 
HISTOLOGY OF THE NORMAL SYNOVIUM 
  The microscopic anatomy of normal synovial tissue often 
falls into three main types [1, 4], based on the structure and 
content of the subintimal layer: ﬁbrous, areolar and adipose 
(Figs. 1-3). In some areas of the body, the subintima may 
consist of periosteum, perimysium or even hyaline or 
ﬁbrocartilage. 
 
Fig. (1). Areolar form of synovium (H and E stain). 
  The areolar type of normal synovium is the most 
specialized form (Fig. 1). It is often crimped into folds, 
which may disappear when stretched or it may contain 
projections or villi. There is usually a continuous layer of 
lining cells often two or three deep on the tissue surface [1-
3]. Immediately beneath these cells are capillaries, with a 
deeper plexus of small arterioles and venules, associated 
with mast cells [5, 6]. Lymphatic vessels are present in all 
types of normal synovial tissue, although they are infrequent 
in the ﬁbrous type of normal synovium. The lymphatic 
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layers of normal synovium [7], while in synovium from RA 
patients lymphatic vessels are widespread and numerous. 
Nerve ﬁbres are present in synovium usually in association 
with blood vessels [8]. The connective tissue matrix in 
normal synovium includes a fine fibrillar matrix with a few 
type I collagen fibres in the intima
, beneath which is a layer 
relatively rich in type I collagen which forms the physical 
membrane. The deepest area of the normal synovium 
consists of a loose connective tissue layer which allows the 
membrane to move freely. Below this loose layer there will 
often be found ligament, tendon or periosteum. 
 
Fig. (2). Adipose form of synovium (H and E stain). 
 
Fig. (3). Fibrous form of synovium (H and E stain). 
  Adipose synovium is found mainly in fat pads but is also 
seen within villi (Fig. 2). There is a complete intimal cell 
layer and a superﬁcial net of capillaries. The intima may lie 
directly on adipocytes but is often separated by a band of 
collagen-rich substratum, while the deeper tissue is fat. Villi 
usually have a central arteriole and venule but can be 
avascular. The amount of fat in villi varies and probably 
decreases with age, with an increase in ﬁbrous tissue. 
  Fibrous synovium is often difﬁcult to deﬁne, consisting 
of ﬁbrous tissue, such as ligament or tendon, on which lies 
an intermittent layer of cells (Fig. 3). Fibrous synovium may 
be indistinguishable from ﬁbrocartilage, especially in the 
annular pads found in ﬁnger joints. 
  Two types of intimal cell have been deﬁned in normal 
synovium, utilizing electron microscopy [9]. The type A 
synoviocyte has cell surface markers identifying it as being 
from macrophage lineage while the type B synoviocyte is of  
ﬁbroblast lineage [1, 2, 11].
  Type A synoviocytes are 
probably true macrophages, derived from blood monocytes, 
while type B synoviocytes are intimal ﬁbroblasts which are 
locally derived [1, 2]. In most disease states, such as 
rheumatoid arthritis, intimal cells increase in number. This is 
probably due to a number of processes, with macrophage 
influx from the vascular compartment under cytokine and 
cell adhesion molecule control being the dominant process 
[1-3, 10]. 
SYNOVIAL MACROPHAGES 
  Macrophages are found both in the intimal and 
subintimal regions of normal synovium. Intimal 
macrophages carry typical macrophage lineage markers. 
They show prominent nonspecific esterase (NSE) activity 
and are strongly positive for CD163 and CD68 but less so 
for CD14 (Fig. 4). Intimal macrophages also express the 
immunoglobulin receptor FcgRIIIa, while subintimal 
macrophages usually express low levels of FcgRIIIa or are 
negative [12]. However, macrophages make up a minority of 
cells in normal intima (Figs. 4,  5), while the numbers in 
inflammatory arthritis increase dramatically and in RA 
synovial tissue account for up to 80% of the intimal layer 
(Figs. 6, 7). A usual pattern is that of a superﬁcial layer of 
macrophages with an intimal phenotype below which is a 
layer of intimal ﬁbroblasts. In the subintima, there may be a 
zone of NSE-weak, strongly CD14
+ FcgRI
+ macrophages, 
associated with venules. There may also be a small number 
of antigen-presenting interdigitating dendritic cells in normal 
synovium [13, 14]. Evidence to date indicates that both 
intimal and subintimal macrophages derive from bone 
marrow via circulating monocytes, many of which probably 
arrive via subintimal venules and migrate to the intima. 
 
Fig. (4). Synovial macrophages. Normal synovium (X200 
magniﬁcation) stained for CD68
+ macrophages (red) (contrast with 
Figs. 5, 6). 
SYNOVIAL FIBROBLASTS 
  Type B synoviocytes have adapted to the production of 
hyaluronan. CD68
- intimal ﬁbroblasts alone demonstrate 
high activity of the enzyme UDP Glucose dehydrogenase 
(UDPGD) which converts UDP-glucose into UDP-
glucuronate, one of the two substrates required by 
hyaluronan synthase for assembly of the hyaluronan polymer 
[15]. In inflammatory arthritis, UDPGD activity in intimal  
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Fig. (5). Normal synovium (X200 magniﬁcation) stained for CD55
+ 
ﬁbroblasts (red). Synovial fibroblasts make up most of the cells in 
the lining layer in the normal synovium intimal layer in contrast to 
RA synovial tissue (contrast with Figs. 4, 7). 
 
Fig. (6). RA synovial tissue (X 200) stained for CD68
+ 
macrophages (red). The majority of the lining layer cells in RA 
synovial tissue are of macrophage origin. 
 
Fig. (7). RA synovial tissue (X 200) stained for CD55
+ ﬁbroblasts 
(red). Unlike normal synovial tissue, the lining layer of RA 
synovial tissue contains fewer fibroblast than macrophage lineage 
cells. 
ﬁbroblasts is reduced. Synovial intimal ﬁbroblasts express 
CD55 (Fig. 5) and this marker can be used to distinguish 
intimal ﬁbroblasts from intimal macrophages [1, 2, 16]. Cell 
suspensions generated from inflamed synovium and grown 
in tissue culture display ﬁbroblast characteristics and 
ramifying processes with production of high levels of 
metalloproteinases [17]. It is not known whether the source 
of these cells is from intimal or subintimal fibroblasts. 
Collagenase and gelatinase expression is variable and not 
necessarily conﬁned to intimal fibroblasts. Synovial intimal 
ﬁbroblasts express several adhesion molecules, including 
vascular cell adhesion molecule-1 (VCAM-1), intercellular 
adhesion molecule (ICAM)-1, CD44 and 1 integrins [1]. 
VCAM-1 expression (Fig. 8) is particularly unusual as it is 
absent from most other normal ﬁbroblast populations, 
whereas CD44 and 1 integrins can be expressed at lower 
levels on normal fibroblasts [1, 2, 18]. VCAM-1 expression 
on intimal ﬁbroblasts may be important in cellular 
trafﬁcking. The ligand for VCAM-1, 4 1 integrin, is present 
on mononuclear leukocytes but not granulocytes, so the 
presence of VCAM-1 on type B synoviocytes in 
inflammatory arthritis may trap macrophages and 
lymphocytes within the synovial membrane while allowing 
neutrophils to egress into the synovial fluid. Complement 
receptor-2 (CR2, CD21) can be induced on synovial 
fibroblasts (but not other fibroblasts) in culture, although it is 
not expressed by normal intimal ﬁbroblasts [19]. Decay 
accelerating factor (DAF), VCAM-1 and CR2 are all 
involved in B lymphocyte survival. Intimal ﬁbroblasts are 
thought to arise by division within synovium either as a 
discrete self-replicating population, distinct from subintimal 
ﬁbroblasts, but more likely they are replaced from the 
subintima. If synovial ﬁbroblasts are disaggregated and 
cultured in vitro, they lose VCAM-1 and CD55 expression 
but the majority, apparently including cells of subintimal 
origin, will readily express these markers following cytokine 
stimulation. It seems likely, therefore, that synovial 
ﬁbroblasts in both the intima and subintima belong to a 
specialized cell population with a propensity to express 
VCAM-1 and CD55. 
OTHER SUB-INTIMAL CELL POPULATIONS 
  Two recent studies have demonstrated the range of cells 
which can be found in the subintimal regions of the normal 
synovial membrane [2, 3]. CD3
+ T cells, including CD4
+ and 
CD8
+ cells, can be found within the normal synovial tissue. 
Some of these cells have memory T cell phenotype and 
while they are likely to be simply trafﬁcking through the 
normal synovium, their role, if any, in the homeostasis of 
synovial tissue is unknown. It is also possible to detect B 
cells, plasma cells and granzyme B positive cells in normal 
synovium, although they are present in small numbers [1-3]. 
INTIMAL MATRIX 
  The intimal matrix has an amorphous or ﬁne  ﬁbrillar 
ultrastructure, containing collagens III, IV, V and VI with 
little type I collagen. Laminin, ﬁbronectin and chondroitin-6-
sulfate-rich proteoglycan are all found in the intimal matrix 
and are all components of basement membrane (along with 
collagen IV), but there is no basement membrane beneath the 
intimal layer in normal synovium [20, 21]. This may be due 
to the absence of entactin, which normally links other 
components in basement membrane together. Intimal 
microﬁbrils include: ﬁbrillin-1 microﬁbrils, forming a 
basketwork around cells, and collagen VI microﬁbrils which The Normal Synovium  The Open Rheumatology Journal, 2011, Volume 5   103 
form a uniform mesh. There are large amounts of hyaluronan 
mainly in the intimal and superficial subintimal layers of 
normal synovium which disappears in the deeper subintimal 
layer. This may indicate diffusion of hyaluronan (HA) from 
the surface towards clearing lymphatics. 
 
Fig. (8). Normal synovium (X200 magniﬁcation) stained for 
VCAM-1 (stained red). 
THE VASCULAR NET 
  Capillaries occur just below or within the intima (Fig. 9). 
Some capillaries are fenestrated and fenestrae tend to face 
the tissue surface; while small venules are prominent deeper 
within the normal synovium [6, 22]. Deeper still in the 
subintimal layer there are larger venules together with 
arterioles and lymphatics (Fig. 10), forming an anastomosing 
array [7]. Vessels with lymphatic staining characteristics are 
prominent in RA synovium and it has been proposed that 
failure of lymphatic drainage of synovial fluid may be a 
cause of villous proliferation in RA synovial tissue. If this is 
correct, it is likely to be due to overloading of existing 
lymphatic channels with HA-rich extracellular fluid and 
leukocytes rather than a lack of lymphatic channels. Apart 
from the fenestration of superﬁcial capillary endothelial cells 
there is little evidence of specialization in synovial 
endothelium. Endothelial cells enlarge in inflamed tissue and 
microvascular proliferation can occur but these events are 
common to inflammation at many sites. Tissue-specific 
adhesion molecules or “addressins” have been sought but no 
evidence of synovium specific vascular markers have been 
found. However, there remains the possibility that 
specialized lymphocyte trafﬁcking pathways apply to 
synovium, possibly based on chemokine-receptor 
interactions. 
THE NERVE SUPPLY 
  Normal synovial tissue has a rich nerve supply [24, 25], 
including the sympathetic nervous system [26] most of the 
nerve supply is around vascular networks although it does 
extend into the intimal layers. Consistently reduced nerve 
supply is seen in synovial tissue from RA patients, especially 
in the more superficial intimal regions. 
CYTOKINE PRODUCTION IN NORMAL SYNOVIUM 
  Although inflammatory cytokine production can be 
detected in normal synovial tissue [1-3], including   
 
 
Fig. (9). Normal synovium (X200 magniﬁcation) stained with 
factor VIII (red) to demonstrate the vascular network. 
 
Fig. (10). Normal synovium (X200 magniﬁcation) stained with 
LYV-1 antibody (red) to demonstrate the lymphatic network. 
interleukin-1 (IL-1) (Fig. 11), interleukin-6 (IL-6) and tumor 
necrosis factor alpha (TNF-) (Fig. 12), it is far less than that 
seen in inflamed synovial tissue such as in RA patients and 
the amount of anti-inflammatory cytokine production, at 
least in the case of IL-1 receptor antagonist (the naturally 
occurring inhibitor of IL-1), is far greater than the amount of 
inflammatory cytokine seen (Fig. 13). This would achieve 
the desired result of suppressing an inflammatory process in 
the normal synovium [1, 2]. Similarly, the amount of 
receptor activator of NF kappa B ligand (RANKL) (an 
essential factor for the development of osteoclasts) seen in 
normal synovial tissue is low [1, 2] and far less than that of 
osteoprotegerin, the naturally occurring inhibitor of RANKL 
(Fig.  14). The net result of this will be to suppress the 
formation of osteoclasts with the normal synovium and 
preserve homeostasis within the normal joint. 
FUNCTION OF THE NORMAL SYNOVIUM 
  The normal synovium provides a deformable packing 
that allows movement of adjacent, relatively non-deformable 
tissues [1, 23]. Areolar synovium may also have specialized 
viscoelastic properties for coping with the stretching, rolling 
and folding it undergoes during joint movement. The 
additional functions of the normal synovium include 
maintenance of an intact non-adherent tissue surface,   104   The Open Rheumatology Journal, 2011, Volume 5  Malcolm D. Smith 
lubrication of cartilage, control of synovial fluid volume and 
composition and nutrition of chondrocytes within joints. 
 
Fig. (11). Normal synovium (X200 magniﬁcation) stained with an 
antibody to detect the IL-1 (positive staining red). No IL-1 
evident in normal synovial tissue. 
 
Fig. (12). Normal synovium (X200 magniﬁcation) stained with an 
antibody to detect the TNF- (positive staining red). No TNF- 
seen in normal synovial tissue. 
 
Fig. (13). Normal synovium (X200 magniﬁcation) stained with an 
antibody to detect the IL-1 receptor antagonist (red). IL-1 receptor 
antagonist mainly expressed by the lining layer macrophages. 
 
MAINTENANCE OF THE TISSUE SURFACE 
  Synovial surfaces must be non-adherent to allow 
continued movement. The production of hyaluronan by 
intimal ﬁbroblasts may be important in inhibiting adhesion. 
Plasminogen activator and DAF from intimal ﬁbroblasts may 
also inhibit ﬁbrin formation and scarring. To retain synovial 
fluid, the intimal matrix must allow free exchange of 
crystalloids and proteins but inhibit rapid transit of the 
viscous hyaluronan solution that is an important component 
of the fluid. These functions presumably reflect the 
combined activities of the intimal macrophages and 
ﬁbroblasts. The vasculature is probably important in both 
intimal cell nutrition and recruitment of new cells. New 
macrophages will be derived from blood monocytes which 
enter the tissue through venules and perivascular ﬁbroblasts 
may provide the main pool of intimal ﬁbroblast precursors. 
 
Fig. (14). Normal synovium (X200 magniﬁcation) stained with an 
antibody against osteoprotegerin (red), a naturally occurring 
inhibitor of osteoclast formation. Most of the OPG is expressed by 
endothelial cells lining blood vessels. 
LUBRICATION 
  The ability of synovial fluid to lubricate cartilage 
surfaces is dependent on the presence of glycoprotein, 
especially a glycoprotein known both as ‘lubricin’ and 
‘superﬁcial zone protein’ because of its localization to the 
surface of both synovium and cartilage [27]. Hyaluronan 
does not appear to contribute to the ability of synovial fluid 
to lubricate cartilage in ex vivo systems but hyaluronan may 
be important in maintaining a film of lubricant on the 
cartilage surfaces in vivo. Hyaluronan is probably the main 
factor responsible for retaining a constant volume of fluid 
during exercise [28]. This constant volume is probably 
important as a cushion for synovial tissue and as a reservoir 
of lubricant for cartilage. It is likely that the rate of synthesis 
of hyaluronan and its exportation into the synovial fluid 
compartment are dependent on the mechanical stimulation of 
intimal ﬁbroblasts and is influenced by the effectiveness of 
the synovial fluid cushion. Thus when synovial fluid volume 
is high, mechanical stresses on intimal ﬁbroblasts are 
reduced with a resultant reduction in the rate of hyaluronan 
production and vice versa. 
  Joint effusions may result from mechanical irritation by 
worn bone and cartilage, with normal composition of 
synovial fluid and excessive production of hyaluronan by The Normal Synovium  The Open Rheumatology Journal, 2011, Volume 5   105 
intimal ﬁbroblasts stimulated by frictional forces, such as in 
osteoarthritis. The cause of joint effusions in an 
inflammatory synovitis is likely to be due to an accumulation 
of exudate similar to a pleural effusion, i.e. an overspill from 
the inflammatory edema in synovial tissue created by 
increased vascular permeability. However recent evidence 
suggests that low-grade inflammatory and immune reaction 
may contribute to the pathogenesis of osteoarthritis, 
suggesting that these two mechanisms of effusion 
development may not be as distinct as originally thought 
[29].
 
CHONDROCYTE NUTRITION 
  The synovium provides the major route of nutrition for 
chondrocytes. In normal joints a surprisingly large 
proportion of hyaline cartilage lies within 50mm of a 
synovial surface. In any one position only a small proportion 
of cartilage is apposed to the other articular surface and 
synovium packs most of the space between less congruent 
areas. In immature joints the subchondral plate is incomplete 
and may contribute to nutrition but in adult joints this route 
is unlikely to be signiﬁcant. Nutrition of areas of cartilage 
that do not come into close contact with synovium must take 
an indirect route. This is most relevant to concave articular 
surfaces. Nutrition may occur by smearing of a thin ﬁlm of 
fluid over these surfaces during movement. However, the 
amount of nutrient carried this way is small. Indirect routes 
through cartilage matrix and the apposed articular cartilage 
may be more important. While the synovial blood vessels 
provide the most direct route for cartilage nutrition, there is 
no evidence that they are structurally adapted to this 
function. 
THE SYNOVIUM AS A SITE FOR PATHOLOGY IN 
INFLAMMATORY JOINT CONDITIONS 
  Synovial joints are involved in a number of 
immunological and inflammatory disorders, including RA, 
systemic lupus erythematosus and spondyloarthritis. 
Understanding the microarchitecture of the normal 
synovium, including the wide range of microscopic 
appearance, cellular inﬁltrates and production of cytokines, 
enzymes and other biologically relevant proteins, will assist 
in understanding the relevant changes in synovial tissue 
architecture and immunopathology in disease states. While 
the architecture of the normal synovium is not as 
homogeneous as previously portrayed in rheumatology 
textbooks, there are consistencies across the broad spectrum 
of normal synovial tissues which can be contrasted with that 
seen in the chronically inflamed synovial tissue. The marked 
increase in synovial lining layer thickness, with a reverse of 
normal ratio of type A to type B synoviocytes, favoring type 
B cells in normal synovium and type A cells in RA, is an 
example of this. Numerous other examples can be given 
including the changes in subintimal cell content, cytokine 
and chemokine production, vascular and lymphatic changes 
as well as production of metalloproteinases and stimulators 
of osteoclast formation. It is important to try and understand 
the hierarchy and chronology of these synovial changes in 
chronic inflammatory arthritides and contrast them with that 
seen in the normal synovium, to identify suitable therapeutic 
targets at various stages in the evolution of a chronic 
inflammatory arthritis. The identiﬁcation of TNF- and IL-
1 as two likely therapeutic targets is an example of how 
such a strategy can lead to useful therapeutic interventions 
being introduced into the management of several chronic 
inflammatory arthritides including RA, psoriatic arthritis and 
ankylosing spondylitis. There is still much to be learned 
about the immunological microenvironment of articular 
tissues, particularly the normal synovium. 
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